QIAcuity digital PCR system

Closed Solicitation Posted

Solicitation number
24-009630
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Paragraph 1:

The National Institutes of Health (NIH) Clinical Center intends to award a firm-fixed price contract to QIAGEN LLC for the QIAcuity Digital PCR System. This dPCR instrument is crucial for viral quantification due to its high precision and sensitivity, especially when dealing with low viral loads or rare viral variants. The NIH is acquiring this equipment under the simplified acquisition procedures of FAR Part 13, which allows for sole source procurement when only one source is reasonably available. Interested parties may submit capability statements by July 2, 2024 in response to this notice.

Paragraph 2:

This acquisition is not set-aside. QIAGEN LLC is the sole manufacturer of the QIAcuity Digital PCR System, and there are no other known vendors that can provide this equipment. The total contract value is not specified, but the required items include one QIAcuity One 5plex PLT-FUL-1 system, related supplies, and freight charges. The place of performance is Bethesda, MD 20892.

Notice text

Notice of Intent Qiagen digital PCR system

  • Product Service Code: 6540 -
  • Ophthalmic Instruments, Equipment, And Supplies
  • NAICS Code: 334516 -Analytical Laboratory Instrument Manufacturing (Small Business Size Standards- 1,250 Average Number of Employees)
  • Place of Performance:

Bethesda, MD 20892 USA

POTS: 24-009630

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH), Office of Purchasing and Contracts (OPC) intends to award a firm-fixed price to QIAGEN LLC19300 Germantown Road, Germantown, MD 20874 on a sole source basis for the QIAcuity Digital PCR System.

The Infectious Diseases Section within the CC Department of Transfusion Medicine works with pathogen detection in huma specimens. Digital PCR (dPCR) is crucial for viral quantification due to its high precision and sensitivity, especially when dealing with low viral loads or rare viral variants, detecting, and quantifying very low concentrations of viral nucleic acids that may be missed by traditional PCR methods.

Line Items:                        Description                                       Quantity

911035                      QIAcuity One 5plex PLT-FUL-1                   1

1002137                        Freight charges                                         1

250001                  QIAcuity Nanoplate 26k 24-well-10              1

250011                 QIAcuity Nanoplate 8.5k 24-well  (10)           1

250101                 QIAcuity Probe PCR Kit (1mL)                          1

250299                 QIAcuity Demo Assay                                        1

This dPCR instrument enables the precise analysis of nucleic acids and is capable of absolute quantification of viral load regardless of the availability of reference material.

Qiagen LLC is the sole manufacturer of the QIAcuity Digital PCR System. There are no other known vendors that can provide this equipment.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Damien Goines, Contract Specialist, damien.goines@nih.gov by July 2nd , 2024, 6:30AM EST.

*** Please send your capability statements ONLY. This IS NOT a request for proposal. ***

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent DNA Synthesizer Frederick, Maryland 21702, United States · NAICS 334516 — No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Service Maintenance for MoFlo Astrio AW10012 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity